Logo for Gelesis Holdings Inc

Gelesis Investor Relations Material

Latest events

Logo for Gelesis Holdings Inc

Q4 2022

Gelesis
Logo for Gelesis

Investor Presentation

7 Sep, 2023
Logo for Gelesis

Q2 2023

14 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Gelesis Holdings Inc

Access all reports
Gelesis Holdings Inc is a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation.